COMMUNIQUÉS West-GlobeNewswire

ChemioCare Expands Proprietary Transdermal Platform
19/10/2018
DEA Registration granted: expands capability to develop controlled substances via transdermal patches NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotech company [...]
BioTelemetry, Inc. to Release Third Quarter 2018 Earnings Results on October 30, 2018
19/10/2018
MALVERN, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2018 earnings on Tuesday, October 30 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call [...]
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
19/10/2018
PITTSBURGH, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from [...]
Matrix Surgical USA Receives 510(k) Clearance for OmniPore® DUROMAX® Surgical Implants for Orbital Reconstruction
18/10/2018
ATLANTA, Ga., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Matrix Surgical USA ( www.matrixsurgicalusa.com ), a leader in the development, manufacturing and commercialization of craniomaxillofacial implants, announced today that [...]
FDA Advisory Committee Recommends Approval of Shire’s Prucalopride (SHP555) for Chronic Idiopathic Constipation
18/10/2018
Intended for U.S. Audience FDA Advisory Committee Recommends Approval of Shire’s Prucalopride (SHP555) for Chronic Idiopathic Constipation If FDA grants approval, prucalopride will be the only readily available 5-HT4 [...]
Abeona Therapeutics nomme João Siffert, M.D., comme Responsable recherche et développement et Directeur médical
18/10/2018
NEW YORK et CLEVELAND, 18 oct. 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), société biopharmaceutique de stade clinique de premier plan spécialisée dans le développement de nouvelles thérapies [...]
Corizon Health Helps Raise the Bar on Correctional Healthcare Excellence
18/10/2018
Company healthcare leaders to present a series of seminars and educational sessions at national conference BRENTWOOD, Tenn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Corizon Health’s correctional healthcare expertise will be [...]
AIT Therapeutics Presented Its High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference
18/10/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 18, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
R1 RCM to Release Third Quarter 2018 Results on November 7
18/10/2018
CHICAGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]
Precision Optics Corporation, Inc. Raises $2 million in Private Placement
18/10/2018
GARDNER, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that it has sold an aggregate of 1,600,000 shares of its common stock at a price of $1. [...]
B. Braun Space Infusion Pump Systems Compatible with Allscripts Sunrise
18/10/2018
BETHLEHEM, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today it has completed the bi-directional integration testing with Allscripts Sunrise™ electronic health record (EHR). The completion of [...]
CTD Holdings Posts Recording of its Webinar on US Clinical Trial
18/10/2018
Webinar recording is on the Company website ALACHUA, Fla., Oct. 18, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the [...]
Retrophin to Report Third Quarter 2018 Financial Results
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report third quarter 2018 financial results on Thursday, November 1, 2018 after the close of the U.S. financial markets [...]
Harvard Bioscience Schedules Third Quarter 2018 Conference Call for October 25 at 4:30 PM ET
18/10/2018
HOLLISTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for [...]
Sarepta Therapeutics to Announce Third Quarter 2018 Financial Results and Recent Corporate Developments on October 24, 2018
18/10/2018
CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, will report third quarter 2018 financial results after the Nasdaq [...]
Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine
18/10/2018
Combines Neon’s Personal Neoantigen Vaccine and Signatera (RUO) Circulating Tumor DNA Biomarker in Metastatic Non-Small Cell Lung Cancer Trial SAN CARLOS, Calif. and CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- [...]
TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018
18/10/2018
WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO) will announce third-quarter 2018 financial results on Thursday, November 1, 2018, after the close of the U.S. financial markets. TESARO’s [...]
Intuitive Surgical Announces Third Quarter Earnings
18/10/2018
SUNNYVALE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), a global technology leader in robotic-assisted, minimally invasive surgery, today announced financial results [...]
Helius Medical Technologies to Release Third Quarter 2018 Financial Results on November 8, 2018
18/10/2018
NEWTOWN, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that third [...]

Pages